MYC and breast cancer: In a recent study, miR-375-3p was notably downregulated and suppressed in BC by blocking the Wnt/β-catenin pathway and the level of the downstream molecules like cyclin D1 and c-Myc, thereby repressing BC cell growth by targeting FZD8 (Li et al., 2020).